About this trial
This is a prospective, single-center, observational study. The inclusion period is set at 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 years or older
Patient informed about the study and who has not opposed the use of their personal medical data
Patient scheduled for arthroscopic shoulder surgery
Disqualifiers
Allergy to local anesthetics or epinephrine
Contraindications to Interscalene Block (e.g., respiratory disease, pneumothorax, pneumonectomy, phrenic or recurrent laryngeal nerve paralysis)
Coagulation disorder
Patients unable to understand the study information and objectives: dementia, psychosis, consciousness disorders, non-French-speaking patients
Trial population
population of patients undergoing shoulder surgery by arthroscopic approach under locoregional anesthesia combining an interscalene block and a superficial cervical plexus block (supraclavicular nerve)
Trial design
Other
Prospective
Treatments tested in this trial
Shoulder surgery
Procedure/Surgeryshoulder surgery by arthroscopic approach under locoregional anesthesia combining an interscalene block and a superficial cervical plexus block
Treatment groups
Trial outcomes
Primary outcomes
Soft point position
The primary outcome is the position of the soft point in relation to the anesthetized area mapped by loco-regional anesthesia
Secondary outcomes
Incision pain
Assessment of incision pain using a simple numerical scale (NRS) from 0 (no pain/not uncomfortable) to 10 (worst possible pain/most uncomfortable)
Postoperative pain
Assessment of postoperative pain using a simple numerical scale (NRS) from 0 (no pain) to 10 (worst possible pain)
Postoperative pain
Assessment of postoperative pain using a simple numerical scale (NRS) from 0 (no pain) to 10 (worst possible pain)
Postoperative pain
Assessment of postoperative pain using a simple numerical scale (NRS) from 0 (no pain) to 10 (worst possible pain)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: